Retroviral vector-mediated transfer of the interferon-alpha gene in chronic myeloid leukemia cells.

Abstract

The transfer and expression of cytokine genes into tumor cells is reportedly a valuable approach to improve the antitumor activity of cytokines in various models. Interferon (IFN)-alpha may induce hematological remission in chronic myeloid leukemia (CML) patients, but only a small proportion of patients achieve a sustained, complete cytogenetic remission. We have investigated the possibility of transducing CML cells with the retroviral vector LIalpha2SN, which encodes the IFN-alpha2 gene. We first optimized the transduction efficiency using the CML-derived K562 cell line. A transduction efficiency of 50% and 85% after three and six infections, respectively, was obtained in K562 cells. We then expressed IFN-alpha2 in CML cells by transducing the latter with LIalpha2SN viral particles. The IFN-alpha secretion after three and six infections was 5,400 and 18,000 U/24 hours/10(6) cells for unselected K562 cells and 7,000 and 290 U/24 hours/10(6) cells for CML CD34+ cells at days 4 and 5. Moreover, the major histocompatibility complex class I antigens were overexpressed after infection with LIalpha2SN in both K562 and CML CD34+ cells. The proliferation (in liquid culture) and the cloning efficiency of these CML cells were significantly decreased after LIalpha2SN treatment. By contrast, the proliferation of cord blood CD34+ cells was not affected by transduction with LIalpha2SN. These results demonstrate the transduction efficiency of CML cells and suggest the possibility of CML cell immunotherapy with retroviral gene transfer of different cytokines such as IFN-alpha.

• Authors: S Salesse, F Moreau-Gaudry, V Pigeonnier-Lagarde, F Mazurier, H Chahine, C Ged, H de Verneuil, J Reiffers, F X Mahon
• Journal: Cancer gene therapy (Cancer Gene Ther) 1998 Nov-Dec Vol. 5 Issue 6 Pg. 390-400 ISSN: 0929-1903 [Print] England
• PMID: 9917094 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antigens, CD34
• Interferon-alpha

Topics

• Animals
• Antigens, CD34 (metabolism)
• Cell Division
• Fetal Blood (immunology)
• Flow Cytometry
• Gene Transfer Techniques
• Genes, MHC Class I (drug effects)
• Genetic Therapy
• Genetic Vectors
• Humans
• Interferon-alpha (genetics)
• K562 Cells
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive (therapy)
• Mice
• Retroviridae (genetics)
• Time Factors
• Transduction, Genetic